Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2019 1
2022 5
2023 2
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Mortality reduction in severe community-acquired pneumonia: key findings from a large randomized controlled trial and their clinical implications.
Vornicu O, Perriens E, Blackman S, Smoos E, Al Sammour C, Oueslati I, Philippot A, Bankier DV, Haddad C, Bendoumou M, François T, Michaux I, Dincq AS, Evrard P, Bulpa P, Honore PM. Vornicu O, et al. Among authors: philippot a. Ann Transl Med. 2023 Oct 25;11(11):395. doi: 10.21037/atm-23-1719. Epub 2023 Aug 18. Ann Transl Med. 2023. PMID: 37970598 Free PMC article. No abstract available.
Hybridization of automation practical courses.
Riera B, Maze C, Debernard S, Philippot A, Galaup M, Panzoli D, Renard D, Pettinelli B, Eynard B. Riera B, et al. Among authors: philippot a. IFAC Pap OnLine. 2022;55(17):115-120. doi: 10.1016/j.ifacol.2022.09.266. Epub 2022 Oct 6. IFAC Pap OnLine. 2022. PMID: 38620756 Free PMC article.
Optimizing endovascular thrombectomy timing and thrombolysis use for ischemic stroke: insights from the SELECT2 and TIMELESS trials.
Nendumba G, Moury J, Van Nieuwenhove M, Robert A, Hauqiert B, Vornicu O, Blackman S, Perriens E, Ghorayeb R, Belhoussine Drissi S, El Nawar P, Philippot A, Dincq AS, Evrard P, Bulpa P, Michaux I, Honore PM. Nendumba G, et al. Among authors: philippot a. Ann Transl Med. 2024 Oct 20;12(5):100. doi: 10.21037/atm-24-64. Epub 2024 Aug 30. Ann Transl Med. 2024. PMID: 39507459 Free PMC article. No abstract available.
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial.
Song JY, Choi WS, Heo JY, Kim EJ, Lee JS, Jung DS, Kim SW, Park KH, Eom JS, Jeong SJ, Lee J, Kwon KT, Choi HJ, Sohn JW, Kim YK, Yoo BW, Jang IJ, Capeding MZ, Roman F, Breuer T, Wysocki P, Carter L, Sahastrabuddhe S, Song M, D'Cor N, Kim H, Ryu JH, Lee SJ, Park YW, Cheong HJ; GBP510/AS03 study group. Song JY, et al. EClinicalMedicine. 2023 Sep 7;64:102140. doi: 10.1016/j.eclinm.2023.102140. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37711219 Free PMC article.
Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial.
Song JY, Choi WS, Heo JY, Lee JS, Jung DS, Kim SW, Park KH, Eom JS, Jeong SJ, Lee J, Kwon KT, Choi HJ, Sohn JW, Kim YK, Noh JY, Kim WJ, Roman F, Ceregido MA, Solmi F, Philippot A, Walls AC, Carter L, Veesler D, King NP, Kim H, Ryu JH, Lee SJ, Park YW, Park HK, Cheong HJ. Song JY, et al. Among authors: philippot a. EClinicalMedicine. 2022 Jul 22;51:101569. doi: 10.1016/j.eclinm.2022.101569. eCollection 2022 Sep. EClinicalMedicine. 2022. PMID: 35879941 Free PMC article.
11 results